Kinetic exclusion assay technology: Characterization of molecular interactions

Assay and Drug Development Technologies

Volumn 2, Issue 6, 2004, Pages 647-657

  Darling, Ryan J ^a   Brault, Pierre Alexandre ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; SERINE PROTEINASE INHIBITOR;

ANTIBODY DETECTION; BINDING AFFINITY; BINDING KINETICS; COST BENEFIT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; INTERMETHOD COMPARISON; ISOTHERMAL TITRATION CALORIMETRY; KINETIC EXCLUSION ASSAY; MEDICAL TECHNOLOGY; MOLECULAR INTERACTION; PROTEIN ENGINEERING; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SOLID; STOICHIOMETRY; SURFACE PLASMON RESONANCE; THERMODYNAMICS;

ALGORITHMS; CHEMISTRY, PHYSICAL; DRUG EVALUATION, PRECLINICAL; KINETICS; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEINS; SOLUTIONS; SPECTROMETRY, FLUORESCENCE; THERMODYNAMICS;

EID: 14644433149     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2004.2.647     Document Type: Review

References (49)

1. Presta LG: Engineering antibodies for therapy. Curr Pharm Biotechnol 2002;3:237-256.
2. Vasserot AP, Dickinson CD, Tang Y, Huse WD, Manchester KS, Watkins JD: Optimization of protein therapeutics by directed evolution. Drug Discov Today 2003;8: 0118-126.
3. Marshall SA, Lazar GA, Chirino AJ, Desjarlais JR: Rational 00design and engineering of therapeutic proteins. Drug Discov Today 2003;8:212-221.
4. Hudson PJ, Souriau C: Engineered antibodies. Nat Med 2003;9:129-134.
5. Lee0 CV, Liang WC, Dennis MS, Eigenbrot C, Sidhu SS, Fu0h G: High-affinity human antibodies from phage-displayed synthetic fab libraries with a single framework scaffold. J Mol Biol 2004;340:1073-1093.
6. Zahnd C, Spinelli S, Luginbuhl B, Amstutz P, Cambillau C, Pluckthun A: Directed in vitro evolution and crystallographic analysis of a peptide-binding single chain antibody fragment (scfv) with low picomolar affinity. J Biol Chem 2004;279:18870-18877.
7. Hanes J, Schaffitzel C, Knappik A, Pluckthun A: Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nat Biotechnol 2000;18:1287-1292.
8. Boder ET, Midelfort KS, Wittrup KD: Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc Natl Acad Sci U S A 2000; 97:10701-10705.
9. Schaffitzel C, 0Hanes J, Jermutus L, Pluckthun A: Ribosome display: an in vitro method for selection and evolution of antibodies from libraries. J Immunol Methods 1999;231: 119-135.
10. Schier R, McCall A, Adams GP, Marshall KW, Merritt H, Yim M, Crawford RS, Weiner LM, Marks C, Marks JD: Isolation of picomolar affinity anti-c-erbb-2 single-chain fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J Mol Biol 1996;263:551-567.
11. Drake AW, Myszka DG, Klakamp SL: Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibrium-based methods. Anal Biochem 2004;328:35-43.
12. Blake RC 2nd, Pavlov AR, Blake DA: Automated kinetic exclusion assays to quantify protein binding interactions in homogeneous solution. Anal Biochem 1999;272:123-134.
13. Chuntharapai A, Gibbs V, Lu J, Ow A, Marsters S, Ashkenazi A, De Vos A, Jin Kim K: Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2. J Immunol 1999;163:766-773.
14. Blake RC 2nd, Delehanty JB, Khosraviani M, Yu H, Jones RM, Blake DA: Allosteric binding properties of a monoclonal antibody and its fab fragment. Biochemistry 2003; 42:497-508.
15. Craig L, Sanschagrin PC, Rozek A, Lackie S, Kuhn LA, Scott JK: The role of structure in antibody cross-reactivity 0between peptides and folded proteins. J Mol Biol 1998; 281:183-201.
16. Nowakowski A, Wang C, Powers DB, Amersdorfer P, Smith TJ, Montgomery VA, Sheridan R, Blake R, Smith LA, Marks JD: Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci U S A 2002;99:11346-11350.
17. Blake DA, Chakrabarti P, Khosraviani M, Hatcher FM, Westhoff CM, Goebel P, Wylie DE, Blake RC 2nd: Metal binding properties of a monoclonal antibody directed toward metal-chelate complexes. J Biol Chem 1996;271: 27677-27685.
18. Delehanty JB, Jones RM, Bishop TC, Blake DA: Identification of important residues in metal-chelate recognition by monoclonal antibodies. Biochemistry 2003;42:14173-14183.
19. Glass TR, Saiki H, Blake DA, Blake RC 2nd, Lackie SJ, Ohmura N: Use of excess solid-phase capacity in immunoassays: advantages for semicontinuous, near-real-time measurements and for analysis of matrix effects. Anal Chem 2004;76:767-772.
20. O'Connell KP, Valdes JJ, Azer NL, Schwartz RP, Wright J, Eldefrawi ME: Assessment of an automated solid phase competitive fluoroimmunoassay for benzoylecgonine in untreated urine. J Immunol Methods 1999;225:157-169.
21. Ohmura N, Lackie SJ, Saiki H: An immunoassay for small analytes with theoretical detection limits. Anal Chem 2001;73:3392-3399.
22. http://www.sapidyne.com. (Last accessed 10/15/04.)
23. Sapidyne: Kinexa 3000 Instrument Manual. Sapidyne, Boise, ID, 2004.
24. Wilson WD: Analyzing biomolecular interactions. Science 2002;295:2103-2105.
25. Myszka DG, Rich RL: Implementing surface plasmon resonance biosensors in drug discovery. Pharm Sci Technol Today 2000;3:310-317.
26. Myszka DG: Kinetic, equilibrium, and thermodynamic analysis of macromolecular interactions with Biacore. Methods Enzymol 2000;323:325-340.
27. McDonnell JM: Surface plasmon resonance: towards an understanding of the mechanisms of biological molecular recognition. Curr Opin Chem Biol 2001;5:572-577.
28. Morton TA, Myszka DG: Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Methods Enzymol 1998;295:268-294.
29. Morton TA, Myszka DG, Chaiken IM: Interpreting complex binding kinetics ftom optical biosensors: a comparison of analysis by linearization, the integrated rate equation, and numerical integration. Anal Biochem 1995;227: 176-185.
30. Myszka DG, He X, Dembo M, Morton TA, Goldstein B: Extending the range of rate constants available from biacore: interpreting mass transport-influenced binding data. Biophys J 1998;75:583-594.
31. Myszka DG: Improving biosensor analysis. J Mol Recognit 1999;12:279-284.
32. Day YS, Baird CL, Rich RL, Myszka DG: Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface- and solution-based biophysical methods. Protein Sci 2002;11:1017-1025.
33. Darling RJ, Kuchibhotla U, Glaesner W, Micanovic R, Witcher DR, Beals JM: Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions. Biochemistry 2002;41:14524-14531.
34. Ward WH, Holdgate GA: Isothermal titration calorimetry in drug discovery. Prog Med Chem 2001;38:309-376.
35. Velazquez-Campoy A, Leavitt SA, Freire E: Characterization of protein-protein interactions by isothermal titration calorimetry. Methods Mol Biol 2004;261:35-54.
36. Leavitt S, Freire E: Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr Opin Struct Biol 2001;11:560-566.
37. Zeder-Lutz G, Zuber E, Witz J, Van Regenmortel MH: Thermodynamic analysis of antigen-antibody binding using biosensor measurements at different temperatures. Anal Biochem 1997;246:123-132.
38. Roos H, Karlsson R, Nilshans H, Persson A: Thermodynamic analysis of protein interactions with biosensor technology. J Mol Recognit 1998;11:204-210.
39. Sigurskjold BW: Exact analysis of competition ligand binding by displacement isothermal titration calorimetry. Anal Biochem 2000;277:260-266.
40. Sigurskjold BW, Berland CR, Svensson B: Thermodynamics of inhibitor binding to the catalytic site of glucoamylase from Aspergillus niger determined by displacement titration calorimetry. Biochemistry 1994;33: 10191-10199.
41. Carter RM, Blake RC, Nguyen TD, Bostanian LA: Near real-time biosensor-based detection of 2,4-dinitrophenol. Biosens Bioelectron 2003;18:69-72.
42. Blake DA, Jones RM, Blake RC 2nd, Pavlov AR, Darwish IA, Yu H: Antibody-based sensors for heavy metal ions. Biosens Bioelectron 2001;16:799-809.
43. Rogers KR, Kohl SD, Riddick LA, Glass T: Detection of 2,4-dichlorophenoxyacetic acid using a fluorescence immunoanalyzer. Analyst 1997;122:1107-1111.
44. Rogers KR, Wang Y, Mulchandani A, Mulchandani P, Chen W: Organophosphorus hydrolase-based assay for organophosphate pesticides. Biotechnol Prog 1999;15: 517-521.
45. Chin TE, Wong RB, Pont JL, Karu AE: Haptens and monoclonal antibodies for immunoassay of imidazolinone herbicides. J Agric Food Chem 2002;50:3380-3389.
46. Khosraviani M, Blake RC 2nd, Pavlov AR, Lorbach SC, Yu H, Delehanty JB, Brechbiel MW, Blake DA: Binding properties of a monoclonal antibody directed toward lead-chelate complexes. Bioconjug Chem 2000;11:267-277.
47. Chiu YW, Li QX, Karu AE: Selective binding of polychlorinated biphenyl congeners by a monoclonal antibody: analysis by kinetic exclusion fluorescence immunoassay. Anal Chem 2001;73:5477-5484.
48. Ohmura N, Tsukidate Y, Shinozaki H, Lackie SJ, Saiki H: Combinational use of antibody affinities in an immunoassay for extension of dynamic range and detection of multiple analytes. Anal Chem 2003;75:104-110.
49. Eldefrawi ME, Azer NL, Nath N, Anis NA, Bangalore MS, O'Connell KP, Schwartz RP, Wright J: A sensitive solid-phase fluoroimmunoassay for detection of opiates in urine. Appl Biochem Biotechnol 2000;87:25-35.